Search Results 611-620 of 16311 for infliximab

  1. A Study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes - Mayo Clinic

    1 Diabetes (T1D). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

  2. Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations - Mayo Clinic

    About this study. To determine the antitumor activity of tipifarnib in patients with locally advanced unresectable or metastatic, relapsed and/or refractory ...

  3. Hematology - Clinical trials

    The primary purpose of this study is to determine if bortezomib, daratumumab, lenalidomide and dexamethasone (Btz-DRd) consolidation followed by daratumumab ...

  4. Cisplatin (intravenous route) - Side effects & uses - Mayo Clinic

    Cisplatin injection is used to treat advanced cancer of the bladder, ovaries, or testicles. Cisplatin is an antineoplastic agent (cancer medicine). It ...

  5. https://www.mayoclinic.org/chinese_organization_concepts.xml

  6. A Multi-center Study A Single IV Infusion Of Allogeneic MPCs In Patients With Rheumatoid Arthritis And Incomplete Response To At Least One TNF Alpha Inhibitor - Mayo Clinic

    A Multi-center Study A Single IV Infusion Of Allogeneic MPCs In Patients With Rheumatoid Arthritis And Incomplete Response To At Least One TNF Alpha Inhibitor.

  7. A Study of SGN-B7H4V in Advanced Solid Tumors - Mayo Clinic

    A side effect is anything a drug does to the body besides treating the disease. Participants will have cancer that has spread in the body near where it started ...

  8. To Evaluate The Long-term Safety And Tolerability Of Acoramidis In Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) - Mayo Clinic

    Key Inclusion Criteria: Participants must have completed the AG10-501 study (ACT-EARLY study) within the past 60 calendar days with a diagnosis of ATTR-CM ...

  9. Hematology - Clinical trials

    The primary purpose of this study is to determine if bortezomib, daratumumab, lenalidomide and dexamethasone (Btz-DRd) consolidation followed by daratumumab ...

  10. Immune-mediated adverse events - Mayo Clinic

    CT chest scan, PET-CT scan and transbronchoscopic biopsy indicating immune-mediated adverse events. Share · Tweet . IMG-20400457.